Clinical Trials Logo

Clinical Trial Summary

1. Explore the efficacy of Ulinastatin use in improving post-operative pulmonary insufficiency and safety in pediatric patients undergoing scheduled CPB open heart surgery to treat Complex Congenital Heart Disease

2. Explore the efficacy of Ulinastatin use in improving intraoperative hemodynamic instability as well as other post-operative organ recuperation and its impact on hospital stay & cost


Clinical Trial Description

Pediatric patients diagnosed with Complex Congenital Heart Disease ready to accept scheduled open-heart surgery under cardiopulmonary bypass (CPB).

This study uses randomized (centralized randomization) & controlled design with open label. Eligible subjects will be randomized to receive either study drug (Ulinastatin) or conventional treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02527811
Study type Interventional
Source Techpool Bio-Pharma Co., Ltd.
Contact
Status Enrolling by invitation
Phase Phase 4
Start date April 2015
Completion date December 2018

See also
  Status Clinical Trial Phase
Unknown status NCT01450956 - The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery N/A
Recruiting NCT02503267 - "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects" N/A
Terminated NCT03437148 - Non-Invasive Shunt Quantification in Interatrial Communication N/A
Active, not recruiting NCT06223321 - The Role of Multislice Computed Tomography in Congenital Heart Diseases in Paediatric Age Group.
Completed NCT03005626 - Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases N/A
Completed NCT01619982 - Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients Phase 4
Recruiting NCT02542683 - Physical Activity and Cognitive Development in Children